EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial

Running, not enrolling

Conditions studied: Depression

In brief

This study will collect EEG data at 3 time points from up to 40 adults who are enrolled in a double clinical trial investigating a device that delivers noninvasive, self-administered external Combined Occipital and Trigeminal Neurostimulation (eCOT-NS) treatment for Major Depressive Disorder (Relivion®DP). Baseline (Pre-treatment) Frontal EEG Alpha Oscillations (Power) will be compared post-stimulation power.

Key facts

Study ID

NCT05178784

Run by

Butler Hospital

People needed

40

Starts

2021-11-16

Expected to finish

2025-11-16

Last updated by the study team

2024-12-05

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets all criteria for participation in the Neurolief-sponsored MOOD clinical trial (NCT04279522) and has been randomized to a treatment group for the double-blind phase.
• Is willing and able to participate in up to 3 additional research visits for EEG data collections.

You may not qualify if…

• none

Where it is running

• Butler Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.